Sector
Israeli RNA therapeutics startups
1 Israeli RNA therapeutics startup is in the directory, with 1 publicly reported funding round totalling $18M. The most recent was Undecimal Bio’s Seed round on Oct 13, 2026.
- Companies
- 1
- Funding rounds
- 1
- Raised
- $18M
- Latest round
- Oct 13, 2026
Companies
| Undecimal BioAI-enabled platform for delivering RNA interference medicines to specific cell types; spun out of Eleven Therapeutics. | Cambridge and Tel Aviv | Oct 13, 2026Seed | $18M |
Most active RNA therapeutics investors
| 1 | 4BIO Capital | 1 | 1 | $18M |
| 2 | IQ Capital | 1 | 1 | $18M |
| 3 | Entree Capital | 1 | 0 | $18M |
| 4 | Harel Tech | 1 | 0 | $18M |
| 5 | Kerna Ventures | 1 | 0 | $18M |
| 6 | Saras Capital | 1 | 0 | $18M |
| 7 | Verve Ventures | 1 | 0 | $18M |
How many Israeli RNA therapeutics startups are there?
1 Israeli RNA therapeutics company has at least one funding round verified against a public report in this directory. Companies without a reported round are not counted.
How much have Israeli RNA therapeutics startups raised?
Rounds with a disclosed amount total $18M across 1 round. Undisclosed rounds are not included in the total.
Which Israeli RNA therapeutics startups raised money most recently?
The latest reported rounds were raised by Undecimal Bio.
Who invests most in Israeli RNA therapeutics startups?
By number of rounds joined: 4BIO Capital (1 round), IQ Capital (1 round) and Entree Capital (1 round).